Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Morganroth

Showing results (21-30 of 214) with videos related to

Pageof 22
Sort By:
Clinical Pharmacology and Therapeutics|December 23, 2006
Cardiac repolarization and the safety of new drugs defined by electrocardiographyJ Morganroth
The American Journal of Cardiology|February 20, 1990
Placement of moricizine in the selection of antiarrhythmic drug therapyJ Morganroth
Cardiology Clinics|August 1, 1986
A noninvasive perspective of electrophysiologic testingJ Morganroth
The American Journal of Cardiology|January 31, 1986
Management of ventricular arrhythmias in patients with congestive heart failure. Second case history presentation and panel discussionJ Morganroth
Medical Times|January 1, 1980
Ambulatory management of ventricular arrhythmiasJ Morganroth
American Heart Journal|April 1, 1992
Proarrhythmic effects of antiarrhythmic drugs: evolving conceptsJ Morganroth
Cardiology|January 1, 1987
Differential utility of antiarrhythmic agentsJ Morganroth
The American Journal of Cardiology|August 12, 1993
Indications for antiarrhythmic suppression of ventricular arrhythmias: a definition of life-threatening ventricular arrhythmiasJ Morganroth
The American Journal of Cardiology|October 19, 1988
Evaluation of antiarrhythmic therapy using Holter monitoringJ Morganroth
The American Journal of Cardiology|August 31, 1987
Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmiasJ Morganroth
Pageof 22

Showing results (21-30 of 214) with videos related to

Sort By:
Pageof 22
Clinical Pharmacology and Therapeutics|December 23, 2006
Cardiac repolarization and the safety of new drugs defined by electrocardiographyJ Morganroth
The American Journal of Cardiology|February 20, 1990
Placement of moricizine in the selection of antiarrhythmic drug therapyJ Morganroth
Cardiology Clinics|August 1, 1986
A noninvasive perspective of electrophysiologic testingJ Morganroth
The American Journal of Cardiology|January 31, 1986
Management of ventricular arrhythmias in patients with congestive heart failure. Second case history presentation and panel discussionJ Morganroth
Medical Times|January 1, 1980
Ambulatory management of ventricular arrhythmiasJ Morganroth
American Heart Journal|April 1, 1992
Proarrhythmic effects of antiarrhythmic drugs: evolving conceptsJ Morganroth
Cardiology|January 1, 1987
Differential utility of antiarrhythmic agentsJ Morganroth
The American Journal of Cardiology|August 12, 1993
Indications for antiarrhythmic suppression of ventricular arrhythmias: a definition of life-threatening ventricular arrhythmiasJ Morganroth
The American Journal of Cardiology|October 19, 1988
Evaluation of antiarrhythmic therapy using Holter monitoringJ Morganroth
The American Journal of Cardiology|August 31, 1987
Antiarrhythmic effects of beta-adrenergic blocking agents in benign or potentially lethal ventricular arrhythmiasJ Morganroth
Pageof 22